Published: June 05, 2015
SumZero asked Daniel Osowsky, long-time SumZero member and founder of Santa Monica based Osowsky Capital, to discuss his recent investment into retail giant Bed Bath and Beyond (BBBY:US). Since Osowsky posted his long recommendation on SumZero in late 2014, the stock has appreciated a meaningful ...
Published: January 23, 2014
So Bad Its Good - JCP will stabilize and valuation will come back to reflect ongoing concern. JCP has seen unprecedented same store sales drops as it tried to change its image. This has ended and they have bottomed on the sales losses. If JCP can stabilize sales and margins then they would have E...
Published: November 21, 2013
Pier 1 Imports Inc missed 2Q13 earnings due to what appear to be transitory execution issues of a lack of marketing emphasis on value during a very promotional period and failure to adequately display newness due to an overemphasis on outdoor furniture, all during the final period of peak investm...
Published: May 24, 2013
The initial taste in people’s mouths when they hear of a Sears’s spinoff is what initially drew us to the situation. Over the last seven years, many value investors have fallen into the “SHLD” trap hoping that the market will value the assets on a “sum of the parts” / liquidation value higher tha...
Published: March 21, 2013
BBBY is still growing, albeit at lower rates, maintaining superb margins to other retail competitors with seasoned management developed in-house and most importantly, generating a massive amount of free cash flow. It also boasts a remarkable track record of sound capital deployment with high retu...
Published: November 29, 2012
While 2012 has been a year of disappointment, there is still very much reason for optimism in the case of the JCP turnaround. While SSS and SSF have declined more dramatically than anticipated, management has succeeded on the cost cutting front and the new JCP, while still very small, has exceede...
Published: September 19, 2012
I would like to suggest a long Walgreen’s (WAG) / short CVS (equal size) pair trade. Currently trading at $35.67 and $47.43 respectively. I expect a 20% return on the long/short position over the next year, with no market or industry correlation.